Tobacco Manufacturers, Growers and Warehousers Stakeholder Discussion December 8, 2010
The U.S. Food and Drug Administration (FDA) Center for
Raleigh Marriott City Center
500 Fayetteville Street
Raleigh, NC, 27601
The U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) is charged with implementing the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) with the goal of reducing the tremendous toll of disease and death caused by tobacco product use.
In order to better ensure the opportunity for meaningful engagement and dialogue between CTP and tobacco manufacturers and growers, a limited number of individuals have been invited to actively participate in the discussion. This approach is based on feedback we have received from stakeholder input on the design of these sessions. Approximately 30 members of the public -- or additional representatives of the tobacco industry groups (including growers) participating in the meeting -- may observe the general sessions held in the main room at the meeting site. A conference line was also provided for additional people to listen via phone.
Stakeholder Discussion Materials
- Registration Policy for Observers (PDF - 38KB)
- Annotated Agenda/Brief Summary of Discussion Topics (PDF - 216KB)
- Stakeholder Discussion Series Sessions Schedule
If you need assistance to access these documents, please email the FDA Center For Tobacco Products.